Suchergebnisse - "Rahman, Omar"

PubPharm (59)

31

Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma

enthalten in: The Cochrane database of systematic reviews | 2016

von Abdel-Rahman, O. | Elsayed, Z.

UpdateIn: Cochrane Database Syst Rev. 2020 Jan 24;1:CD011313. - PMID 31978267

32

S-1-based regimens and the risk of oral and gastrointestinal mucosal injury : a meta-analysis with comparison to other fluoropyrimidines

enthalten in: Expert opinion on drug safety | 2016

von Abdel-Rahman, O. | ElHalawani, H. | Essam-Eldin, S.

33

S-1-based regimens and the risk of leucopenic complications; a Meta-analysis with comparison to other fluoropyrimidines and non fluoropyrimidines

enthalten in: Expert opinion on drug safety | 2016

von Abdel-Rahman, O. | ElHalawani, H. | Essam-Eldin, S.

34

Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with ramucirumab : a systematic review and meta-analysis

enthalten in: Expert opinion on drug safety | 2015

von Abdel-Rahman, O. | ElHalawani, H.

35

Risk of elevated transaminases in cancer patients treated with immune checkpoint inhibitors : a meta-analysis

enthalten in: Expert opinion on drug safety | 2015

von Abdel-Rahman, O. | ElHalawani, H. | Fouad, M.

36

Risk of mucocutaneous toxicities in patients with solid tumors treated with lapatinib : a systematic review and meta-analysis

enthalten in: Current medical research and opinion | 2015

von Abdel-Rahman, O. | Fouad, M.

37

Efficacy and toxicity of sunitinib for non clear cell renal cell carcinoma (RCC) : a systematic review of the literature

enthalten in: Critical reviews in oncology/hematology | 2015

von Abdel-Rahman, O. | Fouad, M.

38

Risk of selected gastrointestinal toxicities in patients with advanced non-small cell lung cancer receiving erlotinib : a systematic review and meta-analysis

enthalten in: Expert review of anticancer therapy | 2015

von Abdel-Rahman, O. | Fouad, M.

39

Risk of fatigue in patients with solid tumors treated with everolimus, temsirolimus or ridaforolimus : a comparative meta-analysis

enthalten in: Expert review of anticancer therapy | 2015

von Abdel-Rahman, O. | Fouad, M.

40

Correlation of cetuximab-induced skin rash and outcomes of solid tumor patients treated with cetuximab : a systematic review and meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2015

von Abdel-Rahman, O. | Fouad, M.